Marriage of resistance and conduit arteries breeds critical limb ischemia

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 3 57-3, 2005, Pages

  Coats, Paul ^a   Wadsworth, Roger ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

Cyclooxygenase; Inflammation; Microvessels; Nitric oxide synthase; Vascular diseases

Indexed keywords

ANGIOGENESIS; ARTERIAL PRESSURE; ARTERY CONSTRICTION; ARTERY DIAMETER; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTERY WALL; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL FUNCTION; BYPASS SURGERY; CAPILLARY PRESSURE; COLLATERAL CIRCULATION; CONFERENCE PAPER; EXTRAVASATION; HUMAN; HYDROSTATIC PRESSURE; INFLAMMATION; LEG BLOOD FLOW; LEG EDEMA; LIMB ISCHEMIA; MICROCIRCULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; RESISTANCE BLOOD VESSEL; THICKNESS; TISSUE STRUCTURE;

ANIMALS; ARTERIES; HUMANS; ISCHEMIA; LEG; NEOVASCULARIZATION, PHYSIOLOGIC; VASCULAR RESISTANCE;

EID: 13944252561     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00773.2004     Document Type: Conference Paper

References (90)

1. 3 during focal cerebral ischemia. J Cereb Blood Flow Metab 9: 1038-1050, 1999.
2. Baffour R, Garb JL, Kaufman J, Berman J, Rhee SW, Norris MA, and Friedmann P. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J Surg Res 93: 219-229, 2000.
3. Baumbach GL, Dobrin PB, Hart MN, and Heistad DD. Mechanics of cerebral arterioles in hypertensive rats. Circ Res 62: 56-64, 1988.
4. Baumbach GL and Hajdu MA. Mechanics and composition of cerebral arterioles in renal and spontaneously hypertensive rats. Hypertension 21: 816-826, 1993.
5. Baumbach GL and Heistad DD. Remodelling of cerebral arteries in hypertension. Hypertension 13: 968-972, 1989.
6. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97: 1114-1123, 1998.
7. Berk BC. Redox signals that regulate the vascular response to injury. Thromb Haemost 82: 810-817, 1999.
8. Bräsen JH, Kivelä A, Röser K, Rissanen TT, Niemi M, Luft FC, Donath K, and Ylä-Herttuala S. Angiogenesis, vascular endothelial growth factor and platelet-derived growth factor-BB expression, iron deposition and oxidation-specific epitopes in stented human coronary arteries. Arterioscler Thromb Vasc Biol 21: 1720-1726, 2001.
9. Brevetti G, Martone VD, De Cristofaro T, Corrado S, Silvestro A, Di Donate AM, Bucur R, and Scopacasa F. High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Thromb Haemost 85: 63-66, 2001.
10. Brevetti G, Silvestro A, Di Giacomo S, Bucur R, Di Donate AM, Schiano V, and Scopacasa F. Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden. J Vasc Surg 38: 374-379, 2003.
11. Brownlee RD and Langille BL. Arterial adaptations to blood flow. Can J Physiol Pharmacol 69: 978-983, 1991.
12. Bund SJ, West KP, and Heagerty AM. Effects of protection from pressure on resistance artery morphology and reactivity in spontaneous hypertensive and Wistar-Kyoto rats. Circ Res 68: 1230-1240, 1991.
13. Cambria RP, Faust G, Gusberg R, Tilson MD, Zucker KA, and Modlin IM. Percutaneous angioplasty for peripheral arterial occlusive disease. Correlates of clinical success. Arch Surg 122: 283-287, 1987.
14. Campbell WB, Ridler BMF, and Szymanska TH. Current management of acute leg ischaemia: results of an audit by the Vascular Surgical Society of Great Britain and Ireland. Br J Surg 85: 1498-1503, 1988.
15. Carter SA and Lezack JD. Digital systolic pressures in the lower limb in arterial disease. Circulation 43: 905-914, 1971.
16. Celletti FL, Hilfiker PR, Ghafouri P, and Dake MD. Effect of human recombinant vascular endothelial growth factor-165 on progression of atherosclerotic plaque. J Am Coll Cardiol 37: 2126-2130, 2001.
17. Cheng CP, Herfkens RJ, and Taylor CA. Abdominal aortic hemodynamic conditions in healthy subjects aged 50-70 at rest and during lower limb exercise: in vivo quantification using MRI. Atherosclerosis 168: 323-331, 2003.
18. Cheng CP, Herfkens RJ, and Taylor CA. Comparison of abdominal aortic hemodynamics between men and women at rest and during lower limb exercise. J Vasc Surg 37: 118-123, 2003.
19. Coats P. Myogenic, mechanical and structural characteristics of resistance arterioles from healthy and ischaemic subjects. Clin Sci Lond 105: 683-689, 2003.
20. Coats P and Hillier C. Differential responses in human subcutaneous and skeletal muscle vascular beds to critical limb ischaemia. Eur J Vasc Endovasc Surg 19: 387-395, 2000.
21. Coats P, Jarajapu YPR, Hillier C, McGrath JC, and Daly C. The use of fluorescent nuclear dyes and laser scanning confocal microscopy to study the cellular aspects of arterial remodelling in critical limb ischaemia. Exp Physiol 88: 547-554, 2003.
22. Conrad MC. Abnormalities of the digital vasculature as related to ulceration and gangrene. Circulation 38: 568-581, 1968.
23. Conrad MC, Anderson JL, and Garrett JB. Chronic collateral growth after femoral artery occlusion in the dog. J Appl Physiol 31: 550-555, 1971.
24. -/- mice. Circulation 99: 3188-3198, 1999.
25. Davis MJ and Hill MA. Signalling mechanisms underlying the vascular myogenic response. Physiol Rev 79: 387-423, 1999.
26. Delp MD, Colleran PN, Wilkerson MK, McCurdy MR, and Muller-Delp J. Structural and functional remodeling of skeletal muscle microvasculature is induced by simulated microgravity. Am J Physiol Heart Circ Physiol 278: H1866-H1873, 2000.
27. Del Zoppo GJ and Hallenbeck JM. Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 98: 73-81, 2000.
28. DeMey JGR, Uitendaal MP, Boonen HCM, Schiffers PMH, and Fazzi G. Structural and functional remodelling of poststenotic arteries in the rat. Adv Exp Med 346: 283-290, 1991.
29. Dickhout JG and Lee RMKW. Structural and functional analysis of small arteries from young spontaneously hypertensive rats. Hypertension 29: 781-789, 1997.
30. Dinenno FA, Tanaka H, Monahan KD, Clevenger CM, Eskurza I, DeSouza CA, and Seals DR. Regular endurance exercise induces expansive arterial remodelling in the trained limbs of healthy men. J Physiol 534: 287-295, 2001.
31. Dora KA, Xia J, and Duling BR. Endothelial cell signaling during conducted vasomotor responses. Am J Physiol Heart Circ Physiol 285: H119-H126, 2003.
32. Dormandy JA. Critical leg ischaemia. In: Vascular Disease in the Limbs, edited by Clement DL and Shepard JT. London: Mosby, 1993, p. 46-52.
33. Dormandy JA, Nahir M, and Ascady G. Fate of the patient with chronic leg ischaemia. J Cardiovasc Surg (Torino) 30: 50-57, 1989.
34. Dulak J, Jozkowicz A, Dembinska-Kiec A, Guevara I, Zdienicka A, Zmudzinska-Grochot D, Florek I, Wojtowicz A, Szuba A, and Cooke JP. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular-smooth muscle cells. Arterioscler Thromb Vasc Biol 20: 659-666, 2000.
35. Dunn WR, Wallis SJ, and Gardiner SM. Remodelling and enhanced myogenic tone in cerebral resistance arteries isolated from genetically hypertensive Brattleboro rats. J Vasc Res 35: 18-26, 1998.
36. Fagrell B. The skin microcirculation and the pathogenesis of ischaemic necrosis and gangrene. Scand J Clin Lab Invest 37: 473-476, 1977.
37. Folkow B. Physiological aspects of primary hypertension. Physiol Rev 62: 347-504, 1982.
38. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circulation 86: 494-501, 2000.
39. Griendling KK and Ushio-Fukai M. Redox control of vascular smooth muscle proliferation. J Lab Clin Med 32: 9-15, 1998.
40. Holdsworth JD. Five-year vascular audit from a district hospital. Br J Surg 78: 601-606, 1991.
41. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker A, and Nakao K. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98: 2108-2116, 1998.
42. Kamata H and Hirata H. Redox regulation of cellular signalling. Cell Signal 11: 1-14, 1999.
43. Kawano H, Motoyama T, Hirai N, Kugiyama K, Yasue H, and Ogawa H. Endothelial dysfunction in hypercholesterolaemia is improved by L-arginine administration: possible role of oxidative stress. Atherosclerosis 161: 375-380, 2002.
44. Khiabani HZ, Anvar MD, Rostad B, Stranden E, and Kroese AJ. The distribution of oedema in the lower limb of patients with chronic critical limb ischaemia: a study with computed tomography. Vasa 28: 265-270, 1999.
45. Kinmonth JB. Investigation of chronic oedemas of the lower limb. Br J Surg 54: 890-891, 1967.
46. Koo EWY and Gotlieb AI. Neointimal formation in the porcine aortic organ culture: cellular dynamics over one month. Lab Invest 64: 743-753, 1991.
47. Lagaud GJ, Masih-Khan E, Kai S, van Breemen C, and Dube GP. Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries. J Vasc Res 38: 578-589, 2001.
48. Langille BL and O'Donnel F. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science 231: 405-407, 1986.
49. Leng GC, Papacosta O, Whincup P, Wannamethee G, Walker M, Ebrahim S, Nicolaides AN, Dhanjil S, Griffin M, Belcaro G, Rumley A, and Lowe GDO. Femoral atherosclerosis in an older British population: prevalence of risk factors. Atherosclerosis 152: 167-174, 2000.
50. Lindsberg PJ, Carpen O, Paetau A, Karjalainen-Lindsberg ML, and Kaste M. Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 94: 939-945, 1996.
51. Lowe G. Pathophysiology of critical ischaemia. In: Critical Leg Ischaemia, edited by Dormandy JA and Stock G. London: Springer-Verlag, 1990, p. 21-32.
52. Ma J, Zhang LF, Yu ZB, and Zhang LN. Time course and reversibility of arterial vasoreactivity changes in simulated microgravity rats. J Gravit Physiol 4: 45-46, 1997.
53. Maier RV and Bulger EM. Endothelial changes after shock and injury. New Horiz 4: 211-223, 1996.
54. Makin AJ, Chung NAY, Silverman SH, and Lip GYH. Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis? Clin Sci Lond 104: 397-404, 2003.
55. McEwan AJ and Ledingham IM. Blood flow characteristics and tissue nutrition in apparently ischaemic feet. Br Med J 3: 220-224, 1971.
56. Meininger GA and Davis MJ. Cellular mechanisms involved in the vascular myogenic response. Am J Physiol Heart Circ Physiol 263: H647-H659, 1992.
57. Morishita R, Sakaki M, Yamamoto K, Iguchi S, Aoki M, Yamasaki K, Matsumoto K, Nakamura T, Lawn R, Ogihara T, and Kaneda Y. Impairment of collateral formation in lipoprotein(a) transgenic mice. Therapeutic angiogenesis induced by human hepatocyte growth factor gene. Circulation 105: 1491-1496, 2002.
58. Mulvany MJ and Aalkjær C. Structure and function of small arteries. Physiol Rev 70: 921-961, 1990.
59. Mulvany MJ, Baumbach GL, Aalkjær C, and Heagerty AM. Vascular remodelling. Hypertension 28: 505-506, 1996.
60. Nakamura T, Saito Y, Kato T, Sumino H, Hoshino J, Ono Z, Sakamaki T, and Nagai R. Flow-mediated vasodilation of a conduit artery in relation to downstream peripheral tissue blood flow during reactive hyperaemia in humans. Jpn Circ J 61: 772-780, 1997.
61. Namba T, Koike H, Murakami K, Aoki M, Makino H, Hashiya N, Ogihara T, Kaneda Y, Kohno M, and Morishita R. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model. Circulation 108: 2250-2257, 2003.
62. Nikol S, Huehns TY, Gonschior P, and Hofling B. Myointimal hyperplasia. Crit Ischaemia 5: 15-27, 1996.
63. Nowicki PT, Flavahan S, Hassanain H, Mitra S, Holland S, Goldschmidt-Clermont PJ, and Flavahan NA. Redox signaling of the arteriolar myogenic response. Circ Res 20: 14-16, 2001.
64. Olsen MH, Wachtell K, Aalkjaer C, Devereux RB, Dige-Petersen H, and Ibsen H. Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low-density lipoproteins in previously treated hypertension. Am J Hypertens 14: 861-867, 2001.
65. Owens GK. Influence of blood pressure on development of aortic medial smooth muscle hypertrophy in spontaneously hypertensive rats. Hypertension 9: 178-187, 1987.
66. Owens GK, Schwartz SM, and McCanna M. Evaluation of medial hypertrophy in resistance vessels of spontaneously hypertensive rats. Hypertension 11: 198-207, 1988.
67. Pell JP and Fowkes FGR. Epidemiology of critical limb ischaemia. Crit Ischaemia 2: 23-29, 1992.
68. Porcu P, Emanueli C, Kapatsoris M, Chao J, Chao L, and Madeddu P. Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischaemia. Circulation 105: 67-72, 2002.
69. Pourageaud F and De Mey JGR. Structural properties of the rat mesenteric small arteries after 4-wk exposure to elevated or reduced blood flow. Am J Physiol Heart Circ Physiol 273: H1699-H1706, 1997.
70. Pourageaud F and De Mey JGR. Vasomotor responses in chronically hyperperfused and hypoperfused rat mesenteric arteries. Am J Physiol Heart Circ Physiol 274: H1301-H1307, 1998.
71. Rajagopalan S, Mohler ER, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, and Annex BH. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease. A phase II randomised, double-blind controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108: 1933-1938, 2003.
72. Resnick N and Gimborne MA. Hemodynamic forces are complex regulators of endothelial gene expression. FASEB J 9: 874-882, 1995.
73. Roberts WG and Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 108: 2369-2379, 1995.
74. Rubanyi GM, Freay AD, Kauser K, Johns A, and Harder DR. Mechanoreception by endothelium: mediators and mechanisms of pressure- and flow-induced responses. Blood Vessels 27: 246-257, 1990.
75. Sauer H, Wartenberg M, and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11: 173-186, 2001.
76. Schiffrin EL. Vascular remodelling and endothelial function in hypertensive patients: effects of antihypertensive therapy. Scand Cardiovasc J 47: 15-21, 1989.
77. 77: Schiffrin EL, Park JB, Intengan HD, and Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 101: 1653-1659, 2000.
78. Shearman C. Will adjuvant pharmacotherapy improve surgical results? Crit Ischaemia 5: 97-100, 1996.
79. Shimpo M, Ikeda U, Maeda Y, Takahashi M, Miyashita H, Mizukami H, Urabe M, Kume A, Takizawa T, Shibuya M, Ozawa K, and Shimada K. AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model. Cardiovasc Res 53: 993-1001, 2002.
80. Smeda JS, Lee RMKW, and Forrest JB. Structural and reactivity alterations of the renal vasculature of spontaneously hypertensive rats prior to and during established hypertension. Circ Res 63: 518-533, 1988.
81. Stanimirovic D and Satoh K. Inflammatory mediators of cerebral endothelium: a role in ischemic brain inflammation. Brain Pathol 10: 113-126, 2000.
82. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, and Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463, 2000.
83. Torres M. Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 8: D369-D391, 2003.
84. Ubbink DT, Kitslaar PJ, Tordoir JHM, Reneman RS, and Jacobs MJHM. Relevance of posturally induced microvascular constriction after re-vascularisation in patients with chronic leg ischaemia. Eur J Vasc Surg 6: 525-532, 1992.
85. Ubbink DT, Spincemaille GH, Reneman RS, and Jacobs MJ. Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. J Vasc Surg 30: 114-121, 1999.
86. Vandenburgh HH. Mechanical forces and their second messengers in stimulating cell growth in vitro. Am J Physiol Regul Integr Camp Physiol 262: R350-R355, 1992.
87. Walsh JH, Bilsborough W, Maiorana A, Best M, O'Driscoll GJ, Taylor MR, and Green DJ. Exercise training improves conduit vessel function in patients with coronary artery disease. J Appl Physiol 95: 20-25, 2003.
88. Walsh JH, Yong G, Cheetham C, Watts GF, O'Driscoll GJ, Taylor RR, and Green DJ. Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects. Eur Heart J 24: 1681-1689, 2003.
89. Yataco AR, Corretti MC, Gardner AW, Womack CJ, and Katzel LI. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease. Am J Cardiol 83: 754-758, 1999.
90. Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, and Bicknell R. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not fibroblast growth factor-induced angiogenesis. J Clin Invest 999: 2625-2634, 1997.